arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

EXICURE, INC.

XCUR
$0.95 0.00 (+0.03%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

EXICURE, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0M
Dividend Yield —
Revenue Growth N/M
Op. Margin None
ROIC -95.6% ↗
FCF / Share $-1.36 ↗
Trailing P/E —
Price / Book 1.5x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0% —
Net Income Profit after all expenses
$-4.95M
↑ +49.0% —
Operating Margin Operating profit as % of sales
-6.4%
↑ +95.9% —
FCF / Share Free cash flow per share
$-1.36
↑ +4.6% —
Long-Term Debt Long-term obligations
$6.87M
↓ -58.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
6
Cash Quality ↑
83

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 41 quarters